First Patient Begins Newly Approved Sickle Cell Gene Therapy

First Patient Begins Newly Approved Sickle Cell Gene Therapy

Source: 
NY Times, NY
snippet: 

On Wednesday, Kendric Cromer, a 12-year-old boy from a suburb of Washington, became the first person in the world with sickle cell disease to begin a commercially approved gene therapy that may cure the condition.